282 related articles for article (PubMed ID: 31939196)
1. MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior.
Vicchio TM; Aliquò F; Ruggeri RM; Ragonese M; Giuffrida G; Cotta OR; Spagnolo F; Torre ML; Alibrandi A; Asmundo A; Angileri FF; Esposito F; Polito F; Oteri R; Aguennouz MH; Cannavò S; Ferraù F
J Endocrinol Invest; 2020 Jul; 43(7):947-958. PubMed ID: 31939196
[TBL] [Abstract][Full Text] [Related]
2. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas.
He Z; Chen L; Hu X; Tang J; He L; Hu J; Fei F; Wang Q
Endocr J; 2019 Aug; 66(8):709-722. PubMed ID: 31061247
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.
Butz H; Likó I; Czirják S; Igaz P; Korbonits M; Rácz K; Patócs A
Pituitary; 2011 Jun; 14(2):112-24. PubMed ID: 21063788
[TBL] [Abstract][Full Text] [Related]
5. CXCL12-regulated miR-370-3p functions as a tumor suppressor gene by targeting HMGA2 in nonfunctional pituitary adenomas.
Cai F; Dai C; Chen S; Wu Q; Liu X; Hong Y; Wang Z; Li L; Yan W; Wang R; Zhang J
Mol Cell Endocrinol; 2019 May; 488():25-35. PubMed ID: 30853598
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
[TBL] [Abstract][Full Text] [Related]
7. Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma.
Krokker L; Nyírő G; Reiniger L; Darvasi O; Szücs N; Czirják S; Tóth M; Igaz P; Patócs A; Butz H
Neurochem Res; 2019 Oct; 44(10):2360-2371. PubMed ID: 30945144
[TBL] [Abstract][Full Text] [Related]
8. circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1.
Du Q; Hu B; Feng Y; Wang Z; Wang X; Zhu D; Zhu Y; Jiang X; Wang H
J Clin Endocrinol Metab; 2019 Jun; 104(6):2419-2434. PubMed ID: 30721952
[TBL] [Abstract][Full Text] [Related]
9. Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas.
Zhu H; Guo J; Shen Y; Dong W; Gao H; Miao Y; Li C; Zhang Y
Clin Cancer Res; 2018 Nov; 24(22):5757-5766. PubMed ID: 29980532
[No Abstract] [Full Text] [Related]
10. MiR-130a-3p Inhibits PRL Expression and Is Associated With Heat Stress-Induced PRL Reduction.
Zhang H; Chen T; Xiong J; Hu B; Luo J; Xi Q; Jiang Q; Sun J; Zhang Y
Front Endocrinol (Lausanne); 2020; 11():92. PubMed ID: 32194503
[TBL] [Abstract][Full Text] [Related]
11. The expression profile of PD-L1 and CD8
Wang PF; Wang TJ; Yang YK; Yao K; Li Z; Li YM; Yan CX
J Neurooncol; 2018 Aug; 139(1):89-95. PubMed ID: 29680903
[TBL] [Abstract][Full Text] [Related]
12. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.
D'Angelo D; Palmieri D; Mussnich P; Roche M; Wierinckx A; Raverot G; Fedele M; Croce CM; Trouillas J; Fusco A
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1128-38. PubMed ID: 22564666
[TBL] [Abstract][Full Text] [Related]
13. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.
Butz H; Németh K; Czenke D; Likó I; Czirják S; Zivkovic V; Baghy K; Korbonits M; Kovalszky I; Igaz P; Rácz K; Patócs A
Pathol Oncol Res; 2017 Jul; 23(3):633-641. PubMed ID: 28004354
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.
Bottoni A; Zatelli MC; Ferracin M; Tagliati F; Piccin D; Vignali C; Calin GA; Negrini M; Croce CM; Degli Uberti EC
J Cell Physiol; 2007 Feb; 210(2):370-7. PubMed ID: 17111382
[TBL] [Abstract][Full Text] [Related]
15. Limitations of high throughput methods for miRNA expression profiles in non-functioning pituitary adenomas.
Darvasi O; Szabo PM; Nemeth K; Szabo K; Spisak S; Liko I; Czirjak S; Racz K; Igaz P; Patocs A; Butz H
Pathol Oncol Res; 2019 Jan; 25(1):169-182. PubMed ID: 29043608
[TBL] [Abstract][Full Text] [Related]
16. miR-200b-3p accelerates progression of pituitary adenomas by negatively regulating expression of RECK.
Wang X; Jia Y; Li Q; Yang Q; Liu Y; Wei B; Niu X; Zhang Y; Luo X; Zhao Z; Wang P
Oncol Res; 2024; 32(5):933-941. PubMed ID: 38686051
[TBL] [Abstract][Full Text] [Related]
17. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs: Suggested role in pituitary adenoma pathogenesis.
Gadelha MR; Kasuki L; Dénes J; Trivellin G; Korbonits M
J Endocrinol Invest; 2013 Nov; 36(10):889-95. PubMed ID: 24317305
[TBL] [Abstract][Full Text] [Related]
19. Potential biomarkers of miRNA in non-functional pituitary adenomas.
Zhang Q; Wang Y; Zhou Y; Zhang Q; Xu C
World J Surg Oncol; 2021 Sep; 19(1):270. PubMed ID: 34503538
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas.
Zhao P; Cheng J; Li B; Nie D; Li C; Gui S; Wang H; Zhang Y
Cell Biol Toxicol; 2021 Aug; 37(4):633-651. PubMed ID: 33400021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]